"Prices are still up by more than 25% so far this year, supported by market volatility and ever-changing U.S. policies. The ...

On April 23, 2025, the U.S. Food and Drug Administration (FDA) granted approval to Akeso Biopharma Co., Ltd.’s penpulimab-kcqx for the first-line treatment of adults with recurrent or metastatic ...

Investing.com -- Shares of Soligenix (NASDAQ: SNGX) climbed 2.9% following the company’s announcement of promising results for its skin cancer treatment, HyBryteTM, in treating cutaneous T-cell ...

Waller expressed a strong belief that tariffs are a one-time price effect, suggesting that businesses may be frozen as a result of these trade measures. He further indicated that it wouldn’t surprise ...

Pony.ai’s latest autonomous driving system boasts a 100% automotive-grade ADK, a significant 70% reduction in BOM costs, and a modular platform architecture for easy adaptation across different ...

On Thursday, cloud storage company Backblaze (NASDAQ: BLZE) saw its shares plummet 8.3% following a scathing short report from Morpheus Research. The report detailed a series of alleged financial ...